[HTML][HTML] Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome

R Prasad, I Hadjidemetriou, A Maharaj… - The Journal of …, 2017 - Am Soc Clin Investig
Primary adrenal insufficiency is life threatening and can present alone or in combination with
other comorbidities. Here, we have described a primary adrenal insufficiency syndrome and …

Management aspects of congenital adrenal hyperplasia during adolescence and transition to adult care

C Balagamage, A Arshad, YS Elhassan… - Clinical …, 2023 - Wiley Online Library
The adolescent period is characterised by fundamental hormonal changes, which affect sex
steroid production, cortisol metabolism and insulin sensitivity. These physiological changes …

[HTML][HTML] A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review

A Maharaj, R Kwong, J Williams, C Smith… - Endocrine …, 2022 - ec.bioscientifica.com
Sphingosine-1-phosphate lyase (SGPL1) insufficiency syndrome (SPLIS) is an autosomal
recessive multi-system disorder, which mainly incorporates steroid-resistant nephrotic …

International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry

I Bacila, N Freeman, E Daniel, M Sandrk… - European journal of …, 2021 - academic.oup.com
Objective Despite published guidelines no unified approach to hormone replacement in
congenital adrenal hyperplasia (CAH) exists. We aimed to explore geographical and …

Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency

R Pofi, A Prete, V Thornton-Jones… - The Journal of …, 2020 - academic.oup.com
Context No consensus exists for optimization of mineralocorticoid therapy in patients with
primary adrenal insufficiency. Objective To explore the relationship between …

Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylase deficiency

I Bacila, J Adaway, J Hawley, S Mahdi… - The Journal of …, 2019 - academic.oup.com
Background Monitoring of hormonal control represents a key part of the management of
congenital adrenal hyperplasia (CAH). Monitoring strategies remain suboptimal because …

Real-world estimates of adrenal insufficiency–related adverse events in children with congenital adrenal hyperplasia

SR Ali, J Bryce, H Haghpanahan… - The Journal of …, 2021 - academic.oup.com
Background Although congenital adrenal hyperplasia (CAH) is known to be associated with
adrenal crises (AC), its association with patient-or clinician-reported sick day episodes …

Treatment of congenital adrenal hyperplasia in children aged 0–3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and …

U Neumann, A Van Der Linde, RE Krone… - European journal of …, 2022 - academic.oup.com
Objectives International guidelines recommend additional salt supplementation during
infancy in classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency …

Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study

I Bacila, NR Lawrence, S Mahdi, S Alvi… - European Journal of …, 2022 - academic.oup.com
Objective There is limited knowledge on the onset of comorbidities in congenital adrenal
hyperplasia (CAH) during childhood. We aimed to establish the health status of children with …

Causes, patterns and severity of androgen excess in 487 consecutively recruited pre-and post-pubertal children

J Idkowiak, YS Elhassan, P Mannion… - European journal of …, 2019 - academic.oup.com
Objective Androgen excess in childhood is a common presentation and may signify sinister
underlying pathology. Data describing its patterns and severity are scarce, limiting the …